Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-04

Clinical Trial Update: Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients [NA]

View source ↗

Summary

A clinical trial comparing ceftolozane/tazobactam with piperacillin/tazobactam for bacteremia in hematologic malignancy patients with neutropenia is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zerbaxa (ceftolozane/tazobactam) (ceftolozane/tazobactam)
  • Zosyn (piperacillin/tazobactam) (piperacillin/tazobactam)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Hematologic Neoplasms, Neutropenia | NA | Status: RECRUITING